Health Canada inspection
Eli Lilly and Company Limited: Health Canada inspection of May 25, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | Eli Lilly and Company Limited |
|---|---|
| City | Indianapolis |
| Province | IN |
| Country | United States |
| Program | GMP |
| Start date | May 15, 2017 |
| End date | May 25, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.